Marico Ltd.'s net profit rose 8% for the quarter ended March 31, 2025, in line with analysts' estimates.
The company's bottom line came in at Rs 343 crore during the January-March period of fiscal 2025, according to an exchange filing on Friday. That compares with a consensus estimate of Rs 336.7 crore by analysts polled by Bloomberg. In the year-ago period, the company posted a net profit of Rs 318 crore.
Marico Q4 FY25 Earnings Highlights (Consolidated YoY)
Revenue up 19.8% at Rs 2,730 crore versus Rs 2,278 crore (Bloomberg estimate at Rs 2,656 crore).
Net profit rises 8% to Rs 343 crore versus Rs 318 crore (Bloomberg estimate at Rs 336.7 crore).
Ebitda up 4% at Rs 458 crore versus Rs 442 crore (Bloomberg estimate at Rs 463.6 crore).
Margin at 16.8% versus 19.4% (Bloomberg estimate at 17.5%).
Dividend
Marico recommended a final dividend of Rs 7 per share for the financial year 2024-25, subject to the approval from the shareholders at the annual general meeting.
The record date for the proposed dividend is set as Aug. 1 and it will be paid to the eligible shareholders on or before Sept. 7.
Including the interim dividend of Rs 3.5 per equity share declared on Jan. 31, the total dividend for the financial year ended March 31, 2025, stands at Rs 10.5 per share of Re 1 each.
Shares of Marico closed 1.79% lower at Rs 697.75 apiece on the NSE, compared to a 0.05% rise in the benchmark Nifty 50. The stock has risen 34.74% in the last 12 months and 9.11% on a year-to-date basis.
Out of 42 analysts tracking the company, 31 recommend a 'buy' rating on the stock, eight suggest 'hold' and three gave 'sell', according to Bloomberg data. The average of 12-month analysts' price target implies a potential upside of 5.4%.
RECOMMENDED FOR YOU

Bajaj Auto Dividend Set At Rs 210 Per Share — Check Record Date


NMDC Q4 Results: Profit Falls 22%; Dividend Declared


Q4 Results Today: Aurobindo Pharma Revenue Up; BrainBees Solutions Net Loss Widens


NTPC Q4 Results: Net Profit Rises 22% To Rs 7,897 Crore
